Evaluation of NT-proBNP to predict outcomes in advanced heart failure

International Journal of Clinical Practice

Volumn 64, Issue 7, 2010, Pages 892-899

  MacGowan, G A ^a   Neely, D ^a   Peaston, R ^a   Wrightson, N ^a   Parry, G ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART TRANSPLANTATION; HUMAN; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TREATMENT OUTCOME;

EID: 77952723034     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02388.x     Document Type: Article

References (23)

1. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990-2005. J Am Coll Cardiol 2007 50: 1282 1290.
2. 2. A simple yet enduring standard. Circulation 2000 101: 1080 1082.
3. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson Jr. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991 83: 778 786.
4. Cheng V, Kazanagra R, Garcia A et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001 37: 386 391.
5. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001 38: 1934 1941.
6. MacGowan GA, Pohwani A, Murali S. Dynamic analysis of exercise oxygen consumption predicts outcomes in advanced heart failure. Congest Heart Fail 2007 13: 313 318.
7. Mullens W, Abrahams Z, Skouri HN et al. Prognostic evaluation of ambulatory patients with advanced heart failure. Am J Cardiol 2008 101: 1297 1302.
8. MacGowan GA, Kormos RL, McNamara DM et al. Predicting short term outcome in severely ill heart failure patients: implications regarding listing for urgent cardiac transplantation and patient selection for temporary ventricular assist device support. J Card Fail 1998 4: 169 175.
9. MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol 1997 79: 1128 1131.
10. Gardner RS, Chong KS, Morton JJ, McDonagh TA. N-terminal brain natriuretic peptide, but not anemia is a powerful predictor of mortality in advanced heart failure. J Card Fail 2005 11 (5 Suppl. S47 53.
11. Rothenburger M, Wichter T, Schmid C et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 2004 23: 1189 1197.
12. Miller WL, Hartman KA, Burritt MF et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007 116: 249 257.
13. Gardner RS, Chong KS, Morton JJ, McDonagh TA. A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure. Eur J Heart Fail 2007 9: 166 271.
14. Iwanaga Y, Nishi I, Furuichi S et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure. J Am Coll Cardiol 2006 47: 42 8.
15. Shah MR, Hasselblad V, Tasissa G et al. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). Am J Cardiol 2007 100: 1427 1433.
16. Gardner RS, Henderson G, McDonagh TA. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones? J Heart Lung Transplant 2005 24: 303 309.
17. Available at: http://www.bsecho.org/index (accessed on 14 January 2010).
18. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005 16: 459 466. (Pubitemid 41725142) (Pubitemid 41725142)
19. Kjaergaard J, Akkan D, Iversen KK, Kober L, Torp-Pederson C, Hassager C. Right ventricular dysfunction as an independent predictor of short-and long-term mortality in patients with heart failure. Eur J Heart Fail 2007 9: 610 616.
20. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995 25: 1143 1153.
21. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009 53: 582 588.
22. Lang CC, Karlin P, Haythe J, Lim TK, Mancini DM. Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail 2009 2: 33 8.
23. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997 95: 2660 2667.